查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1918709

6-氨基烟碱酸甲酯市场依形态、纯度、生产流程、通路和应用划分－2026-2032年全球预测

6-Amino-Nicotinic Acid Methyl Ester Market by Form, Purity, Manufacturing Process, Distribution Channel, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年 6-氨基烟碱酸甲酯市值为 1.3112 亿美元，预计到 2026 年将成长至 1.4151 亿美元，预计到 2032 年将达到 2.2765 亿美元，复合年增长率为 8.20%。

关键市场统计数据
基准年 2025 1.3112亿美元
预计年份：2026年 1.4151亿美元
预测年份 2032 2.2765亿美元
复合年增长率 (%) 8.20%

本文全面介绍了6-氨基烟碱酸甲酯，它是一种在整个农业化学品和医药价值链中具有战略意义的关键化学中间体。

本执行摘要介绍了6-氨基烟碱酸甲酯，它是一种在某些工业应用中日益重要的特种化学中间体。该化合物的理化性质和合成多功能性使其成为农作物保护剂和活性药物成分及中间体的关键中间体。因此，相关人员不仅需要了解该分子的固有效用，还需要了解影响其可用性、品质规格和下游加工性能的更广泛的生态系统。

分析2025年美国关税调整对特种化学中间体筹资策略、合规负担及区域生产决策的影响

美国计划于2025年前后实施的关税措施，其累积影响已波及包括6-氨基烟酸甲酯在内的特种化学中间体的整个供应链。关税调整提高了某些进口原材料和中间体的实际到岸成本，迫使下游製造商重新评估其采购方式和库存缓衝。为此，采购部门加快了供应商资格审核，并扩大了多源采购策略，以降低对单一供应商的依赖风险，并限制原料供应的波动性。

将用途、剂型、纯度、生产路线和分销管道与业务重点和客户期望联繫起来的详细細項分析

细分市场分析揭示了6-氨基烟碱酸甲酯独特的供需动态，这些动态影响其策略决策。根据应用领域，工业需求分为农业化学品应用（主要用于作物保护製剂）和医药应用（作为活性成分和高价值治疗药物的生产中间体）。不同的最终用途要求对纯度和文件记录提出了不同的要求，并要求供应商维持并行的製程控制和测试通讯协定。

关键区域洞察：比较供应可靠性、监管要求和製造实力（美洲、欧洲、中东和非洲、亚太地区）

区域趋势对6-氨基烟碱酸甲酯的采购选择、监管考量和商业策略有显着影响。在美洲，成熟的工业化学品丛集以及与主要农业化学品和製药企业接近性的地理优势，造就了对可靠性和快速物流的重视。因此，服务该地区的供应商前置作业时间的确定性、完善的品质文件以及对当地环境和安全标准的遵守。

企业策略行动展现了以技术整合、敏捷的细分市场供应商、流程稳健性和监管合规性为优先的合作模式。

6-氨基烟碱酸甲酯价值链中主要企业的策略体现了能力整合、製程创新和选择性地域扩张的结合。市场领导致力于建立涵盖製程研发、分析测试和契约製造关係的一体化能力，从而为要求严格的客户提供差异化的技术支援。投资模式着重于持续改善合成效率、控制杂质，并加强可扩展的品质体系，以确保符合多司法管辖区的法规要求。

为领导企业提供切实可行的优先行动方案，以提高流程容错性、加强品质系统、实现采购多元化并拓展增值商业能力。

对于希望巩固市场地位并增强营运韧性的产业领导者而言，该分析提出了几项切实可行的建议。首先，应优先投资于替代合成路线和製程强化，以减少废弃物产生并提高选择性。这将带来环境效益和成本效益。这不仅能够满足日益增长的永续性，还能从长远角度保护您的营运免受原材料价格波动的影响。

本执行摘要的调查方法采用透明的调查方法，结合一手访谈、技术文献综述、实地考察和情境分析，以确保提供可靠的实用见解。一手研究包括对农化和医药终端市场的技术经理、采购专业人员和法规专家进行结构化访谈，并辅以实地考察和情境分析。

本执行摘要的研究结合了定性和定量方法，旨在提供严谨且可直接用于决策的洞见。主要研究包括对农业化学品和製药终端市场的技术负责人、采购负责人和监管专家进行结构化访谈，并在条件允许的情况下辅以现场考察和流程演练。这些工作使我们对合成路线选择、杂质控制方法和商业合约实务有了深入的了解。

总之，我们综合分析了合成方法选择、品质要求和区域趋势如何共同决定整个价值链的策略定位和韧性。

总之，6-氨基烟碱酸甲酯作为一种用途广泛的中间体，占据着重要的市场地位，其策略价值取决于合成方法的选择、纯度要求和区域供应趋势。先进的触媒技术、不断提高的品质要求以及不断变化的贸易政策之间的相互作用，为生产商和买家都带来了挑战和机会。那些投资于工艺创新、加强品质和可追溯性体系，并采取适应不断变化的地缘政治格局的筹资策略的公司，将能够为他们的农化和製药客户提供持续的价值。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 6-氨基烟碱酸甲酯市场（依形式划分）

  • 液体
  • 粉末

9. 6-氨基烟碱酸甲酯市场（依纯度划分）

  • 高纯度
  • 标准级

10. 依生产流程分類的6-氨基烟碱酸甲酯市场

  • 生物催化合成
  • 化学合成

第十一章 6-氨基烟碱酸甲酯市场（依分销管道划分）

  • 直销
  • 批发的
  • 线上销售

第十二章：6-氨基烟碱酸甲酯市场及其应用

  • 杀虫剂
  • 製药
    • 活性成分
    • 中级

13. 各地区 6-氨基烟碱酸甲酯市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 6-氨基烟碱酸甲酯市场（依组别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国6-氨基烟碱酸甲酯市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国6-氨基烟碱酸甲酯市场

17. 中国6-氨基烟碱酸甲酯市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • A & Z Group Co., Ltd.
  • Accela ChemBio
  • Basf SE
  • Bide Pharmatech
  • Changzhou Jintan Yongxiang Chemical
  • Hairui Chemical
  • Ishita Drugs & Industries Ltd.
  • Kavya Pharma
  • Prism Industries Private Limited
  • Quzhou Rundong Chemical
  • Shanghai Macklin Biochemical Co., Ltd.
  • Shunxiang
  • Taizhou Volsen Chemical
  • Tokyo Chemical Industry Co., Ltd.
  • Triveni Interchem Pvt. Ltd.
  • Vcare Medicines Pvt. Ltd.
  • Watson International Ltd.
  • Zhejiang Zetian Fine Chemical
Product Code: MRR-F14BA1B33FDF

The 6-Amino-Nicotinic Acid Methyl Ester Market was valued at USD 131.12 million in 2025 and is projected to grow to USD 141.51 million in 2026, with a CAGR of 8.20%, reaching USD 227.65 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 131.12 million
Estimated Year [2026] USD 141.51 million
Forecast Year [2032] USD 227.65 million
CAGR (%) 8.20%

Comprehensive introduction framing 6-Amino-Nicotinic Acid Methyl Ester as a pivotal chemical intermediate across agrochemical and pharmaceutical value chains with strategic implications

This executive summary introduces 6-Amino-Nicotinic Acid Methyl Ester as a specialized chemical intermediate with growing strategic relevance across select industrial applications. The compound's physicochemical properties and synthetic versatility position it as an enabling intermediate for both agrochemical crop protection agents and pharmaceutical active ingredients and intermediates. Consequently, stakeholders must understand not only the molecule's intrinsic utility but also the broader ecosystem that shapes its availability, quality specifications, and downstream performance.

Transitioning from a purely technical perspective, the introduction situates the compound within contemporary supply chain realities. Raw material sourcing, alternative synthetic routes, and regulatory scrutiny converge to influence procurement strategies. As a result, procurement teams, process chemists, regulatory affairs professionals, and strategic sourcing leaders increasingly seek integrated intelligence that connects process parameters with commercial and compliance implications. This summary sets out to provide that connective tissue by outlining the most material trends, trade impacts, segmentation nuances, regional behaviors, company strategies, and actionable recommendations that follow in the subsequent sections.

Finally, the introduction underscores the need for cross-disciplinary alignment. Decisions regarding manufacturing routes, purity grades, and distribution channels carry immediate implications for time-to-market, quality assurance, and cost management. Therefore, readers are encouraged to interpret the following analysis as a framework for coordinated action across R&D, manufacturing, regulatory, and commercial teams.

The landscape for 6-Amino-Nicotinic Acid Methyl Ester is undergoing transformative shifts driven by technology, sustainability imperatives, and supply chain reconfiguration. Advances in synthetic chemistry, particularly the maturation of biocatalytic routes, are enabling lower-temperature, higher-selectivity pathways that reduce hazardous byproducts and align with tightening environmental expectations. Accordingly, manufacturers and process development teams are revisiting traditional chemical synthesis steps to identify retrofits and hybrid approaches that balance throughput with lifecycle impact reductions.

At the same time, regulatory evolution and customer demand are accelerating adoption of higher-purity grades and more traceable supply chains. Buyers are placing greater emphasis on documented process controls and impurity profiles, prompting suppliers to invest in analytical capabilities and quality management systems. This quality-driven demand coexists with the digitization of operations: process analytics, predictive maintenance, and manufacturing execution systems are enhancing yield consistency and reducing variation across production batches.

Consequently, strategic positioning now requires an integrated approach that considers process innovation, regulatory alignment, and commercial differentiation through demonstrable sustainability credentials. Firms that proactively adopt advanced synthesis techniques, invest in robust quality systems, and articulate verifiable environmental benefits will be better placed to capture long-term partnerships with lead customers in both agrochemical and pharmaceutical segments.

Analysis of how 2025 United States tariff adjustments reshaped sourcing strategies, compliance burdens, and regional production decisions for specialty chemical intermediates

The cumulative impact of United States tariff measures implemented in and around 2025 has rippled through supply chains for specialty chemical intermediates, including 6-Amino-Nicotinic Acid Methyl Ester. Tariff changes increased the effective landed cost of certain imported feedstocks and intermediates, prompting downstream manufacturers to reassess sourcing levers and inventory buffers. In response, procurement teams accelerated supplier qualification efforts and expanded dual-sourcing strategies to mitigate single-origin exposure and reduce volatility in input availability.

Moreover, logistics and customs complexity rose as companies invested in enhanced trade compliance functions to manage classification disputes, import duties, and documentation accuracy. This shift elevated the importance of trade-advisory expertise within corporate procurement and finance teams. Over time, the combination of higher import costs and compliance overhead encouraged some manufacturers to repatriate portions of their value chains or to partner with regional producers that could offer tariff-stable supply, albeit sometimes at the expense of higher local production overheads.

Simultaneously, tariff-driven cost pressures prompted re-evaluation of product formulations and bill-of-materials choices, particularly in crop protection and pharmaceutical intermediate applications where small cost changes can cascade through downstream pricing. Regulatory alignment and longer-term contracts emerged as practical mitigants, with commercial teams negotiating terms that better distribute risk across supplier-customer relationships. Overall, the tariff environment accelerated structural adjustments in sourcing, compliance, and commercial contracting across the value chain.

In-depth segmentation insights connecting application, form, purity, manufacturing route, and distribution channel to operational imperatives and customer expectations

Segmentation analysis reveals distinct demand and production dynamics that shape strategic decisions for 6-Amino-Nicotinic Acid Methyl Ester. Based on application, industrial demand bifurcates between agrochemical uses where the compound is primarily channeled into crop protection formulations and pharmaceutical uses where it serves both as an active ingredient component and as a process intermediate for higher-value therapeutics. These divergent end-use requirements drive different purity and documentation expectations, obliging suppliers to maintain parallel streams of process control and testing protocols.

When considered by form, the product is commercialized as both liquid and powder presentations, each presenting unique handling, storage, and transport considerations. Liquid formulations often streamline downstream dissolution and dosing processes but require attention to corrosion compatibility and cold-chain stability in specific climates. Powder forms can offer longer shelf stability and simpler handling in certain manufacturing lines, yet they increase the need for dust control and particulate management during processing.

Purity segmentation divides demand into high grade and standard grade offerings, with high-grade specifications commanding stricter impurity profiles and traceability that are essential for pharmaceutical applications, while standard grades meet the acceptance criteria for many crop protection synthesis steps. In terms of manufacturing process, biocatalytic synthesis and chemical synthesis routes coexist, with biocatalytic approaches appealing to sustainability-minded buyers and chemical synthesis offering established scalability. Finally, distribution channels vary across direct sales, distributor networks, and online sales, influencing lead times, contractual terms, and the level of technical support accompanying shipments. Taken together, these segmentation dimensions inform how producers prioritize investments in process development, quality systems, and go-to-market structures.

Key regional insights comparing supply reliability, regulatory demands, and manufacturing strengths across the Americas, Europe Middle East & Africa, and Asia-Pacific regions

Regional dynamics exert a powerful influence on sourcing choices, regulatory considerations, and commercial strategies for 6-Amino-Nicotinic Acid Methyl Ester. In the Americas, established industrial chemical clusters and proximity to major agrochemical and pharmaceutical manufacturers create demand patterns that prize reliability and rapid logistics. Consequently, suppliers serving this region emphasize lead-time certainty, robust quality documentation, and compliance with local environmental and safety standards.

Across Europe, the Middle East and Africa, regulatory sophistication and environmental compliance are prominent factors shaping both production and procurement. Buyers in these markets increasingly require comprehensive impurity profiles, sustainability disclosures, and adherence to stringent chemical management frameworks. As a result, suppliers targeting this region invest in advanced analytical laboratories and traceability systems to meet rigorous buyer expectations.

In the Asia-Pacific region, a combination of manufacturing scale, dense supplier networks, and cost-competitive feedstock availability supports a diverse supplier base. This region also exhibits rapid adoption of advanced process technologies in some pockets, alongside strong capabilities in contract manufacturing and toll processing. Transitional dynamics across these regions-shifts in tariff policy, evolving environmental standards, and changing logistics networks-contribute to an international landscape in which regional strengths and constraints must be factored into sourcing and investment decisions.

Corporate strategic behaviors reveal consolidation of technical capabilities, nimble niche providers, and alliance models that prioritize process robustness and regulatory compliance

Corporate strategies among leading companies in the 6-Amino-Nicotinic Acid Methyl Ester value chain reflect a mix of capability consolidation, process innovation, and selective geographic presence. Market leaders focus on building integrated capabilities that span process R&D, analytical testing, and contract manufacturing relationships in order to provide differentiated technical support to demanding customers. Investment patterns emphasize continuous improvement in synthesis efficiency, impurity control, and scalable quality systems that enable multi-jurisdictional compliance.

Smaller, specialized producers often compete on agility, rapid customization, and niche technical expertise, particularly in supporting bespoke pharmaceutical intermediate needs. These firms leverage partnerships with academic groups and contract research organizations to accelerate route scouting and to validate alternative synthetic pathways. At the same time, distributors and channel partners play a critical role in reaching fragmented customer bases and in bundling value-added services such as technical troubleshooting and regulatory dossier support.

Across ownership structures, strategic alliances and tolling agreements are common mechanisms to manage capacity constraints and to de-risk capital-intensive expansions. In short, company-level insights point to a bifurcated competitive landscape where scale and integrated capabilities compete against nimble, technically focused challengers, and where the ability to demonstrate process robustness and regulatory compliance becomes a primary differentiator.

Practical and prioritized actions for leaders to enhance process resilience, strengthen quality systems, diversify sourcing, and expand value-added commercial capabilities

For industry leaders aiming to solidify market position and drive operational resilience, several actionable recommendations emerge from the analysis. First, prioritize investments in alternative synthesis routes and process intensification that reduce waste streams and improve selectivity, thereby delivering both environmental benefits and cost efficiencies. This will not only address tightening sustainability expectations but also insulate operations from feedstock price swings over time.

Second, strengthen quality and traceability systems to meet the divergent requirements of agrochemical and pharmaceutical customers. By implementing rigorous impurity profiling and digitized batch traceability, suppliers can secure long-term contracts and command preferred-supplier status. Third, reassess sourcing networks in light of trade policy volatility; diversify supplier portfolios and develop regional partnerships to mitigate tariff exposure and logistic disruptions.

Fourth, expand commercial offerings to include technical support services and formulation advisory to increase customer stickiness and to differentiate from purely transactional competitors. Finally, pursue targeted collaborations with contract manufacturers and research institutions to accelerate the validation of biocatalytic and hybrid synthesis approaches. Collectively, these measures enable leaders to improve margins, reduce risk, and position themselves as trusted partners to demanding end-users.

Transparent research methodology integrating primary interviews, technical literature review, site-level observations, and scenario analysis to ensure robust and actionable insights

The research underpinning this executive summary combines qualitative and quantitative approaches to deliver rigorous, decision-ready insight. Primary research included structured interviews with technical leaders, procurement professionals, and regulatory specialists across agrochemical and pharmaceutical end markets, supplemented by site visits and process walkthroughs where feasible. These engagements informed a deep understanding of route selection, impurity control practices, and commercial contracting norms.

Secondary research drew on a broad array of publicly available scientific literature, regulatory guidance documents, industry trade publications, and patent filings to validate technical assertions and to trace recent advancements in synthesis and biocatalysis. Data triangulation techniques were applied to reconcile differences between interview perspectives and published sources, ensuring that conclusions reflected corroborated evidence rather than single-source claims.

In addition, scenario analysis explored the operational implications of shifting tariffs, supply chain disruptions, and the adoption curve for novel manufacturing technologies. Throughout, emphasis was placed on transparency of assumptions, traceability of data sources, and the presentation of implications that are immediately actionable for R&D, manufacturing, and commercial stakeholders.

Conclusion synthesizing how synthesis choices, quality expectations, and regional dynamics collectively determine strategic positioning and resilience across the value chain

In conclusion, 6-Amino-Nicotinic Acid Methyl Ester occupies an important niche as a versatile intermediate whose strategic value is shaped by synthesis choices, purity requirements, and regional supply dynamics. The interplay of advanced biocatalytic techniques, heightened quality expectations, and trade policy shifts creates both challenges and opportunities for producers and buyers. Firms that invest in process innovation, strengthen their quality and traceability systems, and adapt sourcing strategies to evolving geopolitical conditions will be better positioned to deliver consistent value to agrochemical and pharmaceutical customers.

Moreover, collaborative approaches-ranging from tolling agreements to research partnerships-offer practical pathways to scale innovation without incurring disproportionate capital risk. Ultimately, the successful players will be those that combine technical excellence with commercial agility, aligning manufacturing capabilities with the specific demands of their target segments. The analysis presented here provides a framework for cross-functional decision-making and highlights the strategic levers that can be deployed to build resilient and differentiated positions in the value chain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 6-Amino-Nicotinic Acid Methyl Ester Market, by Form

  • 8.1. Liquid
  • 8.2. Powder

9. 6-Amino-Nicotinic Acid Methyl Ester Market, by Purity

  • 9.1. High Grade
  • 9.2. Standard Grade

10. 6-Amino-Nicotinic Acid Methyl Ester Market, by Manufacturing Process

  • 10.1. Biocatalytic Synthesis
  • 10.2. Chemical Synthesis

11. 6-Amino-Nicotinic Acid Methyl Ester Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
  • 11.3. Online Sales

12. 6-Amino-Nicotinic Acid Methyl Ester Market, by Application

  • 12.1. Agrochemical
  • 12.2. Pharmaceutical
    • 12.2.1. Active Ingredient
    • 12.2.2. Intermediate

13. 6-Amino-Nicotinic Acid Methyl Ester Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. 6-Amino-Nicotinic Acid Methyl Ester Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. 6-Amino-Nicotinic Acid Methyl Ester Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States 6-Amino-Nicotinic Acid Methyl Ester Market

17. China 6-Amino-Nicotinic Acid Methyl Ester Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. A & Z Group Co., Ltd.
  • 18.6. Accela ChemBio
  • 18.7. Basf SE
  • 18.8. Bide Pharmatech
  • 18.9. Changzhou Jintan Yongxiang Chemical
  • 18.10. Hairui Chemical
  • 18.11. Ishita Drugs & Industries Ltd.
  • 18.12. Kavya Pharma
  • 18.13. Prism Industries Private Limited
  • 18.14. Quzhou Rundong Chemical
  • 18.15. Shanghai Macklin Biochemical Co., Ltd.
  • 18.16. Shunxiang
  • 18.17. Taizhou Volsen Chemical
  • 18.18. Tokyo Chemical Industry Co., Ltd.
  • 18.19. Triveni Interchem Pvt. Ltd.
  • 18.20. Vcare Medicines Pvt. Ltd.
  • 18.21. Watson International Ltd.
  • 18.22. Zhejiang Zetian Fine Chemical

LIST OF FIGURES

  • FIGURE 1. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY HIGH GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY HIGH GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY HIGH GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY STANDARD GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY STANDARD GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY STANDARD GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY BIOCATALYTIC SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY BIOCATALYTIC SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY BIOCATALYTIC SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY CHEMICAL SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY CHEMICAL SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY AGROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY AGROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY AGROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ACTIVE INGREDIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ACTIVE INGREDIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY ACTIVE INGREDIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY INTERMEDIATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY INTERMEDIATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY INTERMEDIATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 112. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 114. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 116. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. GCC 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 133. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 136. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 137. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. G7 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 140. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 142. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 143. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 144. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. NATO 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PURITY, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA 6-AMINO-NICOTINIC ACID METHYL ESTER MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)